Ocular Therapeutix, Inc. Information
Summary
Ocular Therapeutix, Inc. is a public company that has been in the industry for 19 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals areas. The position of the President & CEO is occupied by Antony Mattessich. Its headquarters is located at Bedford, Massachusetts, USA. The number of employees ranges from 100 to 250. The annual revenue of Ocular Therapeutix, Inc. varies between 25M and 100M. Total funding of the company - $188.9M. To connect with Ocular Therapeutix, Inc. employee register on SignalHire.
Industries
Pharmaceuticals
Headquarters Location
Employees Size
100-200 employees
Specialties
Retina, Retinal Disease, Wet AMD, NPDR, DME, Anti-VEGF, Tyrosine Kinase Inhibitors, Ocular Drug Delivery, Sustained Delivery, Ophthalmic Therapies, Ophthalmology
SIC Code
2834, 2836
DMA Code
Greater Boston
Founded
2006
Estimated Annual Revenue
$25M - 100M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2011 | Privately Held | 25 - 100 | 11.9M | $59.2M | |
| 1987 | Public Company | 100 - 250 | 39.2M | $158.2M | |
| 2011 | Public Company | 1 - 25 | 15M | $266M | |
| 1986 | Public Company | 10K - 50K | 15.2B | $0 | |
| 2016 | - | 200-500 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Current employees switched from
Ex-employees switched to
Length of Employment
